Polyhydroxyalkanoate capsule for beverage preparation

By controlling the crystallinity and composition of polyhydroxy fatty acid ester (PHA) series polymers, combining bio-based materials and inorganic fillers, biodegradable capsules have been developed, which solves the problems of fragility and poor thermal stability of existing capsules, and achieves the goal of achieving the problem of crunchy and poor thermal stability of existing capsules. It has improved the barrier to oxygen and water vapor and its mechanical properties, and is degradable under compost conditions.

CN119079314APending Publication Date: 2024-12-06MY TEA CUP AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410715703.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-06-05
Filing Date
2024-06-04
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing capsules are fragile during production and use, have poor thermal stability, and are difficult to maintain good barrier function to oxygen and water vapor, while being difficult to biodegrade.

Method used

Using polyhydroxy fatty acid ester (PHA) series polymers, by controlling their crystallinity and composition, a capsule containing relatively crystalline and weak crystalline polymers was developed, combining bio-based materials and inorganic fillers to form good machinery. and thermal properties of biodegradable capsules.

Benefits of technology

The high-quality beverage extraction of capsules is achieved, maintaining good barrier function to oxygen and water vapor, ensuring mechanical properties and temperature tolerance, and being biodegradable under industrial or living composting conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119079314A_ABST
    Figure CN119079314A_ABST
Patent Text Reader

Abstract

The invention relates to a capsule (1) for preparing a beverage, said capsule comprising a container (2) comprising at least one side wall (4) having a circular edge (5), characterized in that the side wall (4) has a circular edge (5). The sidewalls and rounded edges are formed by injection molding or thermoforming of at least one formulation comprising: (i) at least one polymer P1 selected from polyhydroxyalkanoates (PHA); and (ii) at least one polymer P2 selected from polyhydroxyalkanoates (PHA), said polymer P1 having a crystallinity (KC1) greater than or equal to 50%, and said polymer P2 having a crystallinity (KC2) less than or equal to 30%, preferably less than or equal to 5%.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of closed single-use capsules, biodegradable and compostable by industrial composting and / or by domestic composting, or decomposable by anaerobic digestion (methanizable), containing at least one edible substance. The edible substance may be in powder form for the preparation of beverages intended to be extracted under pressure or temperature (e.g. coffee), or in liquid form for the preparation of beverages designed to be extracted at low pressure and low or ambient temperature, such as lemonade or food supplements. Background Art

[0002] Pre-dosed and pre-packaged portions of coffee are widely used to prepare espresso coffee because of their simplicity and ease of use.

[0003] There are generally two types of capsules on the market, rigid capsules which are generally composed of a container and a seal, and flexible capsules which contain a filter layer. The present invention relates to the first type of capsule.

[0004] Rigid capsules (such as Capsules) are widely used in Europe. Such capsules include a body or container and a seal that is traditionally made essentially of aluminum.

[0005] The final beverage dispensing process follows the following pattern: liquid (such as water or milk) is injected into the capsule to interact with the substance contained in the capsule to produce the desired beverage, and when a sufficient amount of liquid fills the capsule, the capsule opens under fluid pressure to release the prepared beverage.

[0006] For example, the opening of the capsule can be achieved by pressing the extraction face of the capsule with a force, which is applied by increasing the pressure of the fluid inside the capsule on an opening structure provided in the capsule holder, so that when the pressure reaches the rupture stress of the extraction face, the extraction face is torn. The opening structure can be a certain number of raised and recessed elements, such as pyramidal elements, on which the extraction face stretches and tears under the action of the internal pressure of the fluid. Such pressure-controlled beverage preparation has the advantage of being able to produce high-quality beverages.

[0007] There are also capsules whose seal and body are made of plastic material.

[0008] Application WO 2021 / 239982 A1 in the name of the applicant describes a closed capsule whose bottom, side walls and rounded edges are formed by injection molding of at least one formulation comprising:

[0009] (i) at least one polymer selected from polyhydroxybutyrate, and

[0010] (ii) at least one component selected from silicates, vitamin E, plasticized proteins of animal or plant origin or mixtures thereof.

[0011] Thermoplastic capsules used in the prior art may have the disadvantage of being fragile and may sometimes break during the production line or during its use, despite the capsules having very good barrier functions to oxygen and / or water vapor. It has been found in the prior art that during the manufacture of crystalline polyhydroxyalkanoate (PHA) capsules, the mechanical properties of the capsules vary greatly due to the poor thermal stability of PHA. The prior art capsules also deform and / or break when subjected to temperature stress.

[0012] The Applicant has therefore developed new capsules which make it possible to overcome the problems of the prior art while maintaining a good barrier function towards oxygen and / or water vapour.

[0013] The subject of the present invention is therefore to provide a capsule that is rigid but not brittle, while having a good barrier function to oxygen and water vapor, while ensuring constant mechanical properties, good temperature resistance, both during use of the capsule in an extraction machine and during manufacture, while reducing production defects. The capsule is also biodegradable by industrial and / or domestic composting, or even decomposable by anaerobic digestion, and when the capsule is used in an espresso machine, in particular Coffee machines) make it possible to prepare beverages of satisfactory quality, such as coffee. Summary of the invention

[0014] More precisely, the present invention relates to a capsule for preparing a beverage, comprising a container comprising at least one side wall with rounded edges, said side wall and said rounded edges being formed by injection molding or thermoforming of a formulation comprising at least one of:

[0015] (i) at least one polymer P1 selected from polyhydroxyalkanoates (PHA); and

[0016] (ii) at least one polymer P2 selected from polyhydroxyalkanoates (PHA),

[0017] The crystallinity (Kc1) of the polymer P1 is greater than or equal to 50%,

[0018] And the crystallinity (Kc2) of the polymer P2 is less than or equal to 30%, preferably less than or equal to 5%.

[0019] According to one embodiment, the capsule has one or more of the following features:

[0020] - the polyhydroxyalkanoate is selected from polyhydroxybutyrate (PHB) polymers, preferably the polymer P1 and / or the polymer P2 is a PHB copolymer, and / or

[0021] - the polymer P1 contains monomer units M1a of hydroxybutyrate 3HB and monomer units M1b selected from hydroxyvalerate HV, 3-hydroxyhexanoate HH, or 4-hydroxybutyrate 4HB, M1a being different from M1b, and / or the polymer P2 contains monomer units M2a of hydroxybutyrate 3HB and monomer units M2b selected from hydroxyvalerate HV, 3-hydroxyhexanoate HH, or 4-hydroxybutyrate 4HB, M2a being different from M2b, preferably the weight ratio M1b / M1a is less than or equal to 0.07, preferably less than or equal to 0.6, and / or the weight ratio M2b / M2a is greater than or equal to 0.05, preferably in the range of 0.1 to 1, or 0.2 to 0.9, and / or

[0022] - the polymer P1 and / or the polymer P2 are obtained in a bio-based manner by aerobic and / or anaerobic fermentation processes, and / or

[0023] - polymer P1 represents 70 to 99 wt. %, preferably 80 to 98 wt. %, of the total weight of polymers P1 and P2, and / or polymer P2 represents 1 to 30 wt. %, preferably 2 to 20 wt. %, or preferably 3 to 10 wt. %, relative to the total weight of polymers P1 and P2, and / or

[0024] - said formulation represents 50% to 99.9%, preferably 75 to 99.5% by weight, advantageously 90 to 99% by weight of the total weight of said formulation, and / or

[0025] - the formulation further comprises at least one inorganic or organic filler, preferably in a proportion ranging from 0.1 to 50% by weight, preferably from 0.5 to 25% by weight, advantageously from 1 to 15% by weight relative to the total weight of the formulation, preferably the filler being chosen from silicon dioxide, silicates, double hydroxides (HDL), titanium oxides, vitamin E, plasticized animal or vegetable proteins, or mixtures thereof, and / or

[0026] The BET specific surface area of ​​the silicate is in the range of 1 to 250 m 2 / g, and / or the median diameter of the silicate is between 0.5 and 20 μm, and / or the size shape factor of the silicate is greater than or equal to 1:2, and / or - the formulation further comprises at least one polyvinyl alcohol or ethylene vinyl alcohol, preferably in an amount ranging from 1 to 30% by weight, preferably from 2 to 20% by weight, advantageously from 5 to 10% by weight relative to the total weight of the formulation, and / or

[0027] - The capsule:

[0028] - biodegradable and / or compostable under industrial or domestic conditions or by anaerobic digestion, and / or

[0029] - contains at least 80% by weight of bio-based carbon, relative to the total weight of carbon atoms of the capsule, and / or

[0030] - the container comprises a bottom, and the bottom, side walls and rounded edges are formed by injection moulding or thermoforming, preferably with only one layer of the formulation in a mould, and / or

[0031] - the capsule contains a substance in powder or liquid form, the capsule comprises a seal welded around the edge of the container, preferably the seal comprises a single or multilayer film, the film comprises one or more materials selected from the following: biodegradable materials and compostable according to an aerobic biological process and decomposable by anaerobic digestion according to an anaerobic process, preferably the material is selected from paper, non-woven fabrics, cellulose, SiOx layers, polylactic acid polymers, polyhydroxyalkanoates, hybrid layers of organic polymers and inorganic fibers, layers coated with polyvinyl alcohol or ethylene-vinyl alcohol copolymers, preferably layers metallized with aluminum, the layers of the material being optionally separated by adhesive layers, and / or

[0032] - The sealant is composed of a multi-layer film comprising:

[0033] i) paper or filter paper membranes,

[0034] ii) a barrier layer, preferably the barrier layer comprises one or more layers selected from the following:

[0035] - a hybrid barrier layer comprising an organic polymer and an inorganic compound, and / or

[0036] -SiOx barrier check layer, and / or

[0037] - Cellulose barrier layer,

[0038] iii) a nonwoven fabric layer, said nonwoven fabric layer being within the capsule, and / or

[0039] - The seal is composed of the following multiple layers, which are composed of:

[0040] i) barrier layer,

[0041] (ii) a membrane containing a biopolymer, such as polyhydroxyalkanoate PHA, or polybutylene adipate terephthalate PBAT, or polybutylene succinate PBS, or polyaliphatic diacid-co-terephthalate-co-butylene ester PBAlT, or polylactic acid PLA,

[0042] or a multilayer film comprising:

[0043] i) a membrane containing a biopolymer, such as polyhydroxyalkanoate PHA, or polybutylene adipate terephthalate PBAT, or polybutylene succinate PBS, or polyaliphatic diacid-co-terephthalate-co-butylene ester PBAlT, or polylactic acid PLA,

[0044] ii) barrier layer,

[0045] iii) Membranes containing biopolymers such as polyhydroxyalkanoate PHA, or polyadipate-co-terephthalate-co-butylene glycol PBAT, or polybutylene succinate PBS, or polyaliphatic diacid-co-terephthalate-co-butylene glycol PBAlT, or polylactic acid PLA.

[0046] The present invention further relates to a method for manufacturing a capsule according to the present invention, said method comprising the following steps:

[0047] a) preparing the formulation by mixing the ingredients, wherein, optionally, the ingredients may be extruded,

[0048] b) injection molding the formulation obtained in step a) in a mold so as to form at least the side wall and rounded edge layers of the container, optionally one or more layers of the container may be injection molded using a formulation different from the formulation in step a),

[0049] c) filling said container with a substance in powder or liquid form, if the bottom is not molded by injection of said formulation, the filling step is preceded by the steps of placing a single or multiple layer bottom so as to form the container,

[0050] d) optionally, closing the container with a seal to form a capsule,

[0051] Or include the following steps:

[0052] a) preparing the formulation by mixing the ingredients, wherein, optionally, the ingredients may be extruded,

[0053] b) manufacturing a sheet or film by extrusion of said formulation before calendaring or blowing, optionally manufacturing one or more other layers of at least the side wall and the rounded edge of said container by extrusion using at least one formulation different from the formulation in step a), for example using a formulation of PVOH or EVOH,

[0054] c) shaping by thermoforming the sheet or film into a suitable shape,

[0055] d) filling the container with a substance in powder or liquid form, if the bottom is not formed by thermoforming during step c), the filling step is preceded by the step of placing a single or multiple layer bottom in order to form the container,

[0056] e) Optionally, closing the container with a seal to form a capsule.

[0057] The capsules according to the invention generally contain at least 60% by weight of carbon of biobased origin. The concentration of biobased carbon can be determined according to standard EN 16640. According to said standard, the total carbon fraction of the capsule should be determined and the biobased percentage (C14 by radiocarbon measurement) should be measured in the capsule.

[0058] Advantageously, the capsules according to the invention comprise at least 80% by weight of biobased carbon, preferably at least 90% by weight of biobased carbon, relative to the total weight of carbon atoms of the capsule.

[0059] The capsules according to the present invention are stable in storage. As the capsules are well sealed against oxygen and water vapor, the capsules can be stored and preserve the contents for at least 12 months before consumption.

[0060] The capsule according to the present invention Machine compatibility: The present invention can be used for other common machine formats.

[0061] The capsules according to the present invention have a barrier function, i.e., their permeability to oxygen at 23°C and 50% RH (relative humidity) at 0.21 atm is typically less than 3.5×10 -3 cm 3 / capsule / 24 hours, preferably equal to or less than 3.0×10 at 23°C and 50% RH at 0.21 atm -3 cm 3 / capsule / 24 hours, further preferably at 23 ° C and 50% RH at 0.21 atm is equal to or less than 2.90 × 10 -3 cm 3 / capsule / 24 hours, measured according to ASTM F1307 or according to ISO15105-2.

[0062] Further, the capsule according to the present invention is made biodegradable by industrial composting and / or domestic composting, advantageously the capsule is compostable by both industrial composting and domestic composting.

[0063] The capsules of the invention therefore have both a very satisfactory barrier function to gases, in particular to oxygen, and good mechanical and thermal properties, since they are sufficiently rigid without being brittle, while at the same time ensuring a constant quality during manufacture and their use.

[0064] Other characteristics, variants and advantages achieved by the invention will become more apparent on reading the following description and embodiments, which are provided as illustration of the invention but not as a limitation thereof. BRIEF DESCRIPTION OF THE DRAWINGS

[0065] [ Figure 1 ] is a schematic cross-sectional view of a container implemented according to the present invention.

[0066] [ Figure 2 ] is a schematic cross-sectional view of a capsule implemented according to the present invention.

[0067] [ Figure 3 ] is a graph showing the flow of different formulations and polymers as a function of time. DETAILED DESCRIPTION

[0068] The invention relates to sealed capsules in the form of individual portions, containing at least one edible substance in powder or liquid form for preparing a beverage suitable for extraction under pressure, such as coffee, tea, chocolate, lemonade or a dietary supplement.

[0069] Preferably, the invention relates to a capsule for preparing a beverage, comprising a container comprising at least one side wall with rounded edges and a bottom. The capsule is intended to be extracted under pressure and contains a substance in powder or liquid form for preparing a beverage.

[0070] According to one embodiment, the capsule further comprises a seal located opposite the bottom of the capsule.

[0071] According to a first variant, the bottom is configured to be perforated by a blade of the coffee production machine so that the blade provides an opening for the injection of fluid. In this case, the bottom forms an injection wall through which the fluid is injected and which will be discharged through the seal after passing through the contents of the capsule.

[0072] According to a second variant, the blade of the coffee production machine passes through the capsule at the seal, which acts here as an injection wall, and the fluid injected therein is discharged through said bottom.

[0073] According to the invention, the side wall and the rounded edge are formed by injection molding or thermoforming of at least one formulation according to the invention.

[0074] According to a first embodiment, the side walls, rounded edges and bottom are formed by injection moulding or thermoforming of at least one formulation according to the invention, while the seal is formed by a single-layer or multi-layer film.

[0075] According to a second embodiment, the bottom and the seal are formed by a monolayer or multilayer film. In this case, during the injection molding or thermoforming of at least one of the formulations according to the invention, a support can also be formed outside the side walls and the rounded edges, which can serve to support the bottom formed by the monolayer or multilayer film. This support can have, for example, a cross-shaped structure, which is then obtained during the injection molding or thermoforming of at least one of the formulations according to the invention.

[0076] In case the substance is in powder form, extraction of the beverage may be performed at a pressure in the range of 2 to 20 bar and at a temperature in the range of 30 to 100°C, for example.

[0077] In case the substance is in liquid form, extraction of the beverage may be performed at a pressure in the range of 2 to 7 bar and at, for example, room temperature or a temperature in the range of 20 to 45°C.

[0078] According to the present invention, the formulation of the capsule comprises:

[0079] (i) at least one polymer P1 selected from PHAs; and

[0080] (ii) at least one second polymer P2 selected from PHA,

[0081] The crystallinity (Kc1) of the polymer P1 is greater than or equal to 50%, and

[0082] The degree of crystallinity (Kc2) of said polymer P2 is less than or equal to 30%, advantageously less than or equal to 15% and even more preferentially less than or equal to 5%.

[0083] As described above, in capsule-holder systems, the capsule is typically adapted to open on a protruding element under the action of increased pressure when liquid is injected into the capsule, or for other systems, the capsule is adapted to have an outlet opening created by mechanical perforation, spikes, or other holes in the membrane or bottom.

[0084] Preferably, the capsule according to the invention consists of at least 85% by weight of biodegradable and compostable (aerobic bioprocess) and / or degradable by anaerobic digestion (anaerobic bioprocess), preferably 100% of biodegradable and compostable (aerobic bioprocess) and / or degradable by anaerobic digestion (anaerobic bioprocess).

[0085] "Biodegradable" refers to materials that break down under the action of living organisms (such as bacteria, fungi, or algae) and are converted into, for example, carbon dioxide, water, and / or methane.

[0086] "Compostable" refers to an object made of biodegradable materials that decomposes readily under controlled conditions, such as those specified by industrial and domestic compostability standards.

[0087] The capsules according to the invention advantageously meet the compostability standard EN 13432, being biodegradable under industrial composting conditions.

[0088] EN 13432 specifies technical requirements and procedures for determining the compostability of materials.

[0089] EN 13432 defines the properties that materials and products should have in order to be considered compostable and biodegradable.

[0090] Biodegradation may be tested according to standards such as ISO 14855, ISO 17556 or ISO 14851. For example, one of such tests requires that to be considered "industrially compostable" at least 90% of a material must be biodegraded within six months under controlled conditions.

[0091] There are also similar tests that enable certification of home composting. There are currently no international or European standards, only national standards for home composting. Therefore, according to the French recommendation, the capsules according to the invention are biodegradable under home composting conditions. More specifically, the capsules meet the NF T51-800 (2015) standard, i.e. at least 90% of the capsules are biodegraded under controlled conditions at 25°C + / - 5°C in less than 365 days (maximum 12 months). The capsules according to the invention will generally also meet the Australian standard AS5810 (2010).

[0092] Thus, the capsule according to the invention generally comprises a container and a seal welded around the edge of said container. Thus, the container comprises a bottom and a side wall with a rounded edge. The rounded edge secures the capsule when it is inserted into the machine and forms a sealing zone when used in said machine, such as a coffee machine.

[0093] The capsule container is usually shaped starting from the formulation by integral molding or thermoforming of the bottom, sidewalls and rounded edges. The integral molding or thermoforming can be carried out in one or more layers, provided that at least one layer consists of the formulation described in the present invention. When two layers are involved, usually each layer will consist of a different formulation. For example, if the molding of the container is produced in two layers, a layer of the formulation according to the present invention and a barrier layer consisting of, for example, polyvinyl alcohol (PVOH) or ethylene vinyl alcohol (EVOH) can be used.

[0094] When three layers are involved, generally, at least two different layers may be used, of which at least one layer will consist of the formulation according to the invention. One of the three layers may then be a barrier layer consisting of, for example, PVOH or EVOH.

[0095] According to a preferred embodiment, the container is molded in a single layer formulation.

[0096] According to the present invention, the formulation of the capsule comprises:

[0097] (i) at least one polymer P1 selected from PHAs; and

[0098] (ii) at least one second polymer P2 selected from PHA,

[0099] The crystallinity (Kc1) of the polymer P1 is greater than or equal to 50%, and

[0100] The crystallinity (Kc2) of the polymer P2 is less than or equal to 30%, preferably less than or equal to 15%, even more preferably less than or equal to 5%.

[0101] Thus, P1 is more crystalline, whereas P2 is less crystalline, or even more amorphous.

[0102] The inventors have thus discovered that the effectiveness of the oxygen and / or water vapour barrier and the flexibility of the capsules is due to the nature of the additives, as well as to the crystallinity of the polymer used, in particular when it comes to polymers of the polyhydroxyalkanoate (PHA) family.

[0103] The inventors have found that the properties of the capsule are affected by the crystallinity of its formulation. Thus, the higher the crystallinity, the more brittle the molded part will be.

[0104] Crystallinity refers to the degree of structural order in a solid and is related to the order of polymer molecular chains.

[0105] Crystallinity can be measured by differential thermal analysis or DTA, or differential scanning calorimetry or DSC, preferably DSC. Said methods are particularly useful for determining the glass transition temperature (called Tg), the crystallization temperature (called Tc), and the melting temperature (called Tm) of a polymer.

[0106] Completely amorphous polymers have neither crystallization nor melting temperatures and are thermally characterized by DSC only by their glass transition temperature, Tg.

[0107] The properties of a plastic are strongly influenced by its crystallinity. The higher the crystallinity, the more rigid the molded part, but also the more brittle it is. The degree of crystallinity (also called the level of crystallinity) is influenced by the chemical structure and the thermal history, such as cooling conditions during manufacturing or post-thermal treatment.

[0108] To determine the crystallinity Kc of polymer Pi, the melting enthalpy of polymer Pi measured by DSC (ΔHmes) was compared with the value of completely crystalline polymers in the literature (ΔHlit).

[0109] thereby

[0110] [Mathematical formula 1] KC = ΔHmes / ΔHlit.

[0111] There are databases in the literature, in particular scientific papers describing the enthalpy of fusion of various completely crystalline polymers. Thus, the enthalpy of fusion of completely crystalline polymers, in particular PHA polymers, more particularly PHB polymers, is available to the skilled person.

[0112] The melting enthalpy ΔHlit of a fully crystalline PHB polymer (such as PHBH or PHBV polymer) is 146 J / g, as reported in: Vorleak Chea et al., J.APPL.POLYM.SCI.2015, DOI: 10.1002 / APP.41850, or Zonglin Li et al., Polymers 2020, 12, 1300; doi: 10.3390 / polymer12061300, or Sunny Modi et al., European Polymer Journal 47 (2011) 179–186.

[0113] For amorphous polymers, there is no melting peak, so the melting enthalpy is zero. For example, the melting enthalpy of a polymer such as P3HB4HB is close to zero.

[0114] Crystallinity has a significant impact on hardness, density, transparency and diffusion, and thus on the gas barrier properties.

[0115] In this application, "polymer" refers to homopolymers and / or copolymers.

[0116] The polymers P1 are relatively crystalline polymers. The formulations according to the invention may comprise one or more crystalline polymers P1.

[0117] In the present invention, the term "rather crystalline" polymer refers to a polymer having a crystallinity KC1 greater than or equal to 50%.

[0118] Polymer P2 is a weakly crystalline polymer, or even a relatively amorphous polymer.The formulation according to the invention may comprise one or more weakly crystalline or even amorphous polymers P2.

[0119] The "weakly crystalline" polymer defined in the present invention refers to a polymer having a crystallinity Kc2 ranging from 5% to 49%.

[0120] A "rather amorphous" polymer as defined herein refers to a polymer having a crystallinity Kc2 of less than or equal to 5%.

[0121] The more crystalline polymer P1 has a melting point. When the polymer P2 is amorphous, it has no melting point.

[0122] According to one embodiment, the glass transition temperature Tg of the crystalline polymer P1 used in the present invention is greater than -10°C, preferably in the range of -5 to 5°C (measured by DSC, temperature ramp +10°C / min).

[0123] According to one embodiment, the glass transition temperature Tg of the amorphous polymer P2 used in the present invention is less than -10°C, preferably in the range of -20°C to -10°C (measured by DSC, temperature ramp +10°C / min).

[0124] According to one embodiment, the crystalline polymer P1 used according to the invention has a melting temperature ranging from 120° C. to 200° C. (measured by DSC, temperature ramp +10° C. / min).

[0125] According to one embodiment of the present invention, the formulation comprises silicon dioxide (SiO2) and / or titanium dioxide (TiO2). SiO2 and / or TiO2 play a role in the barrier function and are also nucleating agents. The particle size of silicon dioxide (SiO2) is strictly greater than 100nm, more preferably strictly less than 500nm. The particle size of TiO2 is strictly greater than 460nm, more preferably strictly greater than 460nm and strictly less than 3900nm.

[0126] "Particle size" refers to the median diameter as measured, for example, by laser particle size distribution.

[0127] Typically, all ingredients in the formulation are biodegradable.

[0128] According to one embodiment, the PHA is selected from the PHB series (poly(hydroxybutyrate)).

[0129] Within the framework of the present invention, a "polymer of the PHB family" is understood to mean a polymer comprising at least one repeating unit of the formula -(O-CH(CH3)-CH2CO)-.

[0130] According to one embodiment, the PHA is selected from poly 3-hydroxybutyrate-co-3-hydroxyhexanoate polymers (PHBH), polyhydroxybutyrate / hydroxyvalerate polymers (PHBV), poly 3-hydroxybutyrate 4-hydroxybutyrate (P3HB4HB) polymers, and mixtures thereof.

[0131] The polymer PHBH includes 3-hydroxybutyrate (3HB) monomer units and 3-hydroxyhexanoate (3HH) monomer units.

[0132] The 3HB monomer unit has the formula (1):

[0133] [Chemical formula 1]

[0134]

[0135] The 3HH monomer unit has the formula (2):

[0136] [Chemical formula 2]

[0137]

[0138] The PHBV polymer includes 3-hydroxybutyrate (3HB) monomer units and hydroxyvalerate (HV) monomer units.

[0139] The HV monomer unit has the formula (3):

[0140] [Chemical formula 3]

[0141]

[0142] The polymer P3HB4HB includes 3-hydroxybutyrate (3HB) monomer units and 4-hydroxybutyrate (4HB) monomer units.

[0143] The 4HB monomer unit has the formula (4):

[0144] [Chemistry 4]

[0145]

[0146] Preferably, in the formulation according to the invention, the polymer PHBV, when present, is a relatively crystalline polymer, whereas the polymers PHBH and P3HB4HB, when present, are weakly crystalline or even amorphous polymers.

[0147] According to one embodiment, the polymer P1 is a polymer obtained by aerobic and / or anaerobic fermentation engineering of bio-based materials.

[0148] According to one embodiment, the polymer P1 contains monomer units M1a of hydroxybutyrate 3HB and monomer units M1b selected from hydroxyvalerate HV or 3-hydroxyhexanoate HH or 4-hydroxybutyrate 4HB, M1a being different from M1b.

[0149] Preferably, monomer units M1b represent 5% by weight, preferably less than 3% by weight or even less than 1% by weight of the total weight of monomer units M1a and M1b.

[0150] According to one embodiment, the polymer P2 is a polymer obtained by aerobic and / or anaerobic fermentation engineering of bio-based materials.

[0151] According to one embodiment, the polymer P2 contains monomer units M2a of hydroxybutyrate 3HB and monomer units M2b selected from hydroxyvalerate HV or 3-hydroxyhexanoate HH, or 4-hydroxybutyrate 4HB, M2a being different from M2b.

[0152] Preferably, monomer units M2b represent at least 5% by weight, preferably at least 20% by weight, even at least 30% by weight, based on the total weight of monomer units M2a and M2b.

[0153] According to one embodiment, the weight ratio M1b / M1a is less than or equal to 0.07, preferably less than or equal to 0.6, and / or the weight ratio M2b / M2a is greater than or equal to 0.05, preferably ranging from 0.1 to 1, or preferably from 0.2 to 0.9.

[0154] Preferably, polymers P1 and P2 comprise no monomer units other than PHA, preferably polymers P1 and P2 comprise no monomer units other than monomer units from M1a, M1b, M2a and M2b, respectively.

[0155] Polymers P1 and P2 are commercially available or can be prepared according to methods known to those skilled in the art.

[0156] According to such an embodiment, the additive(s) represent from 70 to 99% by weight, preferably from 80 to 98% by weight, preferably from 85 to 97% by weight, based on the total weight of polymers P1 and P2.

[0157] According to such an embodiment, the additive(s) represent from 1 to 30%, preferably from 2 to 20% by weight, preferably from 3 to 15% by weight, relative to the total weight of polymers P1 and P2.

[0158] According to one embodiment, the formulation comprises from 50 to 99.9% by weight, preferably from 75 to 99.5% by weight, advantageously from 90 to 99% by weight, of polymers P1 and P2, preferably P1 and P2 are chosen from PHBV polymers and P3HB4HB polymers, the PHBV polymers being preferably crystalline polymers and the P3HB4BH polymers being preferably amorphous polymers, relative to the total weight of the formulation.

[0159] According to one embodiment, the formulation further comprises (iii) at least one inorganic or organic filler, which is preferably selected from silica, silicates, vitamins (preferably vitamin E), peroxides, plant or animal waxes, plasticized animal or plant proteins, or mixtures thereof, preferably selected from silica, silicates, vitamin E, plasticized animal or plant proteins, or mixtures thereof.

[0160] The inorganic or organic filler may represent, for example, 0.5 to 25% by weight, advantageously 1 to 15% by weight, of the total weight of the formulation.

[0161] According to one embodiment, the silicate is chosen from aluminosilicates, aluminum and magnesium silicates, preferably from aluminosilicates or LDH (layered double hydroxides).

[0162] Aluminum and magnesium silicates include montmorillonite.

[0163] According to one embodiment, the silicate is selected from phyllosilicates, preferably phyllosilicates.

[0164] According to one embodiment, the multilayer silicate is selected from kaolinite, halloysite and mixtures thereof.

[0165] According to one embodiment, the aluminosilicate is kaolin.

[0166] According to one embodiment, the silicate, preferably an aluminosilicate, has a particle size having a median diameter ranging from 0.5 μm to 20 μm (measured by laser particle size analysis), and / or a particle size having a median diameter ranging from 1 to 250 μm. 2 The specific surface area of ​​??g is measured by the BET (Brunauer, Emmett and Teller) method.

[0167] Typically, such silicates have a size factor greater than or equal to 1:2, advantageously greater than or equal to 1:4, in particular greater than or equal to 1:6, referred to as silicates with an acicular shape. The shape factor can be determined microscopically, for example by scanning electron microscopy (SEM). Acicular fillers are preferentially oriented in the direction of flow during capsule injection, and therefore parallel to the capsule wall surface, and are used for:

[0168] - Mechanical reinforcement in the long direction (less capsule breakage), and

[0169] - Increased tortuosity of the polymer matrix resulting from the presence of particles with needle-like shape, providing additional barrier.

[0170] According to one embodiment, the silicate, which generally has a needle-like shape, will have one or even two nanometer dimensions (1 nm to 100 nm), provided that the silicate contains at least one micrometer dimension (1 μm to less than 1 mm) in order to meet food contact standards. This nanometer / micrometer size can be used to introduce small amounts of silicate compared to micron carbonates or talc, and has at least 2 advantages:

[0171] -Reduce the weight of the finished part while improving the material's O2 barrier effect

[0172] -Increase the stress tolerance and Young's modulus of the capsule.

[0173] According to one embodiment, the formulation comprises:

[0174] 50 to 99.9% by weight, preferably 75 to 99.5% by weight, advantageously 90 to 99% by weight, of polymers P1 and P2,

[0175] 0.1 to 50% by weight, preferably 0.5 to 25% by weight, more preferably 1 to 15% by weight of an ingredient selected from the group consisting of silicates, vitamin E, plasticized proteins of animal or vegetable origin, and mixtures thereof,

[0176] Relative to the total weight of the formulation.

[0177] According to one embodiment, the formulation comprises:

[0178] 50 to 99.9% by weight, preferably 75 to 99.5% by weight, advantageously 90 to 99% by weight, of polymers P1 and P2,

[0179] 0.1 to 50% by weight, preferably 0.5 to 25% by weight, advantageously 1 to 15% by weight of an ingredient chosen from silicates, vitamin E and mixtures thereof,

[0180] Relative to the total weight of the formulation.

[0181] According to one embodiment, the formulation comprises:

[0182] (i) 50 to 98 wt. %, preferentially 75 to 95 wt. %, advantageously 80 to 90 wt. % of polymer P1,

[0183] (ii) 0.5 to 20% by weight, preferably 1 to 15% by weight, advantageously 2 to 10% by weight, of polymer P2,

[0184] (iii) 0.1 to 50% by weight, preferably 0.5 to 25% by weight, advantageously 1 to 15% by weight, of inorganic or organic fillers,

[0185] Relative to the total weight of the formulation.

[0186] According to one embodiment, the formulation comprises:

[0187] (i) 50 to 98% by weight, preferably 75 to 95% by weight, advantageously 80 to 90% by weight, of a polymer P1 comprising monomer units M1a of hydroxybutyrate 3HB and monomer units M1b selected from hydroxyvalerate (HV) or 3-hydroxyhexanoate (HH) or 4-hydroxybutyrate (4HB),

[0188] (ii) 0.5 to 20% by weight, preferably 1 to 15% by weight, advantageously 2 to 10% by weight, of a polymer P2 comprising monomer units M2a of hydroxybutyrate (3HB) and monomer units M2b selected from hydroxyvalerate (HV) or 3-hydroxyhexanoate (HH) or 4-hydroxybutyrate (4HB),

[0189] (iii) 0.1 to 50% by weight, preferably 0.5 to 25% by weight, advantageously 1 to 15% by weight, of inorganic or organic fillers,

[0190] Relative to the total weight of the formulation,

[0191] Advantageously, P1 and P2 are obtained by aerobic and / or anaerobic fermentation engineering of bio-based materials.

[0192] According to one embodiment, the formulation comprises:

[0193] (i) 50 to 98 wt. %, preferentially 75 to 95 wt. %, advantageously 80 to 90 wt. % of polymer P1,

[0194] (ii) 0.5 to 20% by weight, preferentially 1 to 15% by weight, advantageously 2 to 10% by weight, of polymer P2,

[0195] (iii) 0.1 to 50%, preferably 0.5 to 25%, advantageously 1 to 15% by weight of an inorganic or organic filler selected from silicates, vitamin E and mixtures thereof,

[0196] Relative to the total weight of the formulation.

[0197] According to one embodiment, the formulation comprises, relative to the total weight of the formulation:

[0198] (i) 50 to 98 wt. %, preferably 75 to 95 wt. %, advantageously 80 to 90 wt. % of a polymer P1, P1 comprising monomer units M1a of hydroxybutyrate 3HB and monomer units M1b selected from hydroxyvalerate (HV), 3-hydroxyhexanoate (HH) or 4-hydroxybutyrate (4HB), monomer M1b representing less than 5 wt. %, preferably less than 3 wt. %, or even less than 1 wt. % of the total weight of monomers M1a and M1b,

[0199] (ii) 0.5 to 20% by weight, preferably 1 to 15% by weight, advantageously 2 to 10% by weight, of a polymer P2, P2 comprising monomer units M2a of hydroxybutyrate (3HB) and monomer units M2b selected from hydroxyvalerate (HV) or 3-hydroxyhexanoate (HH) or 4-hydroxybutyrate (4HB), monomer M2b representing at least 5% by weight, preferably at least 20% by weight, or even at least 30% by weight of the total weight of monomers M2a and M2b,

[0200] (iii) 0.1 to 50% by weight, preferably 0.5 to 25% by weight, advantageously 1 to 15% by weight, of an organic or inorganic filler selected from silicates, vitamin E and mixtures thereof,

[0201] Advantageously, P1 and P2 are obtained by aerobic and / or anaerobic fermentation engineering of bio-based materials.

[0202] According to one embodiment, the formulation comprises, relative to the total weight of the formulation:

[0203] (i) 50 to 98% by weight, preferably 75 to 95% by weight, advantageously 80 to 90% by weight, of a polymer P1 comprising monomer units M1a of hydroxybutyrate 3HB and monomer units M1b selected from hydroxyvalerate (HV), 3-hydroxyhexanoate (HH) or 4-hydroxybutyrate (4HB), monomer M1b representing less than 5% by weight, preferably less than 3% by weight, even less than 1% by weight of the total weight of monomers M1a and M1b,

[0204] (ii) 0.5 to 20% by weight, preferably 1 to 15% by weight, advantageously 2 to 10% by weight, of a polymer P2, P2 comprising monomer units M2a of hydroxybutyrate (3HB) and monomer units M2b selected from hydroxyvalerate (HV) or 3-hydroxyhexanoate (HH) or 4-hydroxybutyrate (4HB), monomer M2b representing at least 5% by weight, preferably at least 20% by weight, or even at least 30% by weight of the total weight of monomers M2a and M2b,

[0205] (iii) 0.1 to 50% by weight, preferably 0.5 to 25% by weight, advantageously 1 to 15% by weight, of aluminosilicates,

[0206] Relative to the total weight of the formulation,

[0207] Advantageously, P1 and P2 are obtained by aerobic and / or anaerobic fermentation engineering of bio-based materials.

[0208] According to one embodiment, the formulation comprises:

[0209] 50 to 98.9 wt. %, preferably 75 to 97.5 wt. %, advantageously 80 to 94 wt. % of a polymer selected from PHBV polymers, which are relatively crystalline polymers, and P3HB4HB polymers, which are relatively amorphous polymers,

[0210] 0.1 to 40% by weight, preferably 0.5 to 25% by weight, more preferably 1 to 15% by weight of an ingredient selected from silicates, aluminum, plasticized proteins of animal or vegetable origin, vitamin E or mixtures thereof,

[0211] optionally 1 to 30% by weight, preferably 2 to 20% by weight, advantageously 5 to 10% by weight, of PVOH or EVOH, relative to the total weight of the formulation,

[0212] Advantageously, P1 and P2 are obtained by aerobic and / or anaerobic fermentation engineering of bio-based materials.

[0213] According to one embodiment, the formulation comprises:

[0214] 50 to 98.9 wt. %, preferably 75 to 97.5 wt. %, advantageously 80 to 94 wt. % of a polymer selected from PHBV and P3HB4HBs, the PHBV polymer being a relatively crystalline polymer and the P3HB4BH polymer being a relatively amorphous polymer,

[0215] from 0.1 to 40% by weight, preferentially from 0.5 to 25% by weight, advantageously from 1 to 15% by weight, of aluminosilicates,

[0216] - optionally 1 to 30 wt. %, preferably 2 to 20 wt. %, advantageously 5 to 10 wt. % of PVOH or EVOH,

[0217] Relative to the total weight of the formulation,

[0218] Advantageously, P1 and P2 are obtained by aerobic and / or anaerobic fermentation engineering of bio-based materials.

[0219] When the formulation comprises a mineral or organic filler chosen from silicon dioxide, silicates, vitamin E or plasticized animal or vegetable proteins, the formulation may (optionally) further comprise a mineral filler different from silicates, a peroxide-type product, a vitamin different from vitamin E, a vegetable or animal wax. According to such an embodiment, the one or more additives may represent 0.05 to 20% by weight, preferentially 0.1 to 15% by weight, advantageously 1 to 10% by weight, relative to the total weight of the formulation.

[0220] Preferably, the formulation consists entirely of materials that are biodegradable and compostable (aerobic bioprocessing) and / or decomposable by anaerobic digestion (anaerobic bioprocessing).

[0221] The formulations realized in the present invention are generally produced by extrusion, preferably by twin-screw extrusion. The formulations can then be obtained in the form of granules.

[0222] Typically, the capsules comply with standard EN 13432 which has been in force since 2002.

[0223] Anaerobic digestion is a technology based on the degradation of organic matter by microorganisms under controlled conditions and in the absence of oxygen (thus in an anaerobic environment, unlike composting which is an aerobic reaction).

[0224] Typically, during its use, a capsule containing at least one substance for preparing a beverage in powder or liquid form is inserted into a capsule-holder of a beverage preparation machine before closing the capsule-holder and starting to prepare the beverage.

[0225] The capsule contains a substance in powder or liquid form for preparing a beverage. The beverage will preferably be coffee, tea, a chocolate product, preferably coffee. The substance in powder form for preparing coffee may be roasted and ground coffee, soluble coffee or a mixture thereof.

[0226] The capsules according to the present invention can be prepared according to the following method:

[0227] a) preparing a formulation by mixing the ingredients, wherein the ingredients may optionally be extruded;

[0228] b) injection molding the formulation in a mold so as to form at least the layer of the side walls and the rounded edges of the container, preferably the layer forming the bottom, the side walls and the rounded edges of the container, and optionally one or more of the other layers of the container, typically using at least one formulation different from the one used in step a), for example using a PVOH or EVOH formulation,

[0229] c) optionally, filling the container with a substance in powder or liquid form, if the bottom is not injection-molded with said formulation, the filling step is preceded by the step of placing a bottom of a single-layer or multi-layer type in order to form the container,

[0230] d) Optionally, closing the container with a seal to form a capsule.

[0231] Alternatively, the capsules according to the present invention may be prepared by the following method:

[0232] a) preparing the formulation by mixing the ingredients, wherein the ingredients may optionally be extruded;

[0233] b) making a sheet or film by extrusion of said formulation before calendering or blow molding, optionally using at least one formulation different from the formulation in step a), making at least the side wall and one or more other layers of the rounded edge of said container by extrusion, for example using a formulation of PVOH or EVOH,

[0234] c) shaping at least the side walls and the rounded edges of the container by thermoforming the sheet into or into a suitable shape

[0235] d) optionally, filling the container with a substance in powder or liquid form, if the bottom is not produced by thermoforming during step c), the filling step is preceded by the step of placing a bottom of the single-layer or multi-layer type, thereby forming the container,

[0236] e) Optionally, closing the container with a seal to form a capsule.

[0237] Preferably, the manufacturing method comprises only one step of injection moulding or thermoforming using the formulation defined in the present invention.The container according to the present invention will then consist of only one layer having the formulation defined in the present invention according to the above embodiments.

[0238] The container thickness typically ranges from 0.2 to 1 mm, preferably from 0.3 to 0.8 mm.The bottom of the container is easily perforated and may optionally include grooves.

[0239] The rounded edge is formed during the production of the container by thermoplastic injection into a mould of appropriate shape. The rounded edge may have a width ranging from 1 to 4 mm. The main function of the rounded edge is to abut against the edge of the capsule holder of the beverage making device during the phase of extracting the beverage (e.g. coffee), thereby allowing the capsule to be firmly fixed during the pressure rise.

[0240] Thus, the mould for injection moulding or the mould for thermoforming will generally comprise a bottom or support, side walls and rounded edges in order to obtain each layer of the container, which will preferably consist of a single layer of the formulation of the invention.

[0241] According to a first mode, the side walls, rounded edges and bottom are formed by injection moulding or thermoforming of at least one formulation according to the invention, while the seal is formed by a monolayer or multilayer film.According to a first embodiment, the mould will contain the bottom, the side walls and the rounded edges.

[0242] According to a second embodiment, the support, side walls and rounded edges are formed by injection molding or thermoforming of at least one formulation according to the invention, while the seal and bottom are formed by a single or multilayer film. According to a second embodiment, the mold will contain the support (for example in the form of a cross), the side walls and the rounded edges.

[0243] The seal is usually of calibrated size so as to match the contour of the circular edge of the capsule container, thereby closing the container.

[0244] Thus, the substance, preferably ground coffee, in powder form, is trapped within the hollow container. Typically, the seal will be bonded or heat-welded to the circular edge of the capsule container.

[0245] According to one embodiment, the seal consists of a biodegradable and compostable film (aerobic bioprocess) and / or a film degradable by anaerobic digestion (anaerobic bioprocess). Typically, the seal may be a single or multilayer film with a total thickness ranging from 90 to 300 μm.

[0246] Thus, the seal may consist of one or more layers of material selected from paper, nonwoven fabrics, cellulose, barrier layers, wherein the material layers may be separated by adhesive layers, whereby the adhesive layers may be biodegradable and compostable (aerobic biological processes) and / or decomposable by anaerobic digestion (anaerobic biological processes).

[0247] The nonwoven fabric includes polylactic acid (PLA) or a nonwoven fabric polyhydroxyalkanoate nonwoven fabric (PHA), or polybutylene succinate (PBS), or polybutylene adipate-terephthalate (PBAT), or polybutylene adipate-co-terephthalate (PBAlT), wherein the aliphatic diacid may be, for example, sebacic acid.

[0248] Barrier layers include SiOx or Al2O3 layers, PLA layers, hybrid layers of organic polymers and inorganic fibers, layers coated with PVOH (polyvinyl alcohol) or EVOH (ethylene-vinyl alcohol copolymer), layers metallized (e.g. with aluminum), and barrier layers produced by evaporation (plasma or air vacuum deposition).

[0249] "Barrier" refers to the ability of a material to restrict or reduce the passage of oxygen and / or water vapor or moisture, and can then be referred to as a barrier to oxygen and / or moisture. Hybrid layers of organic polymers and inorganic compounds include layers of silicic acid polycondensates modified with organic groups and inorganic compounds. Organic groups include polycaprolactone, chitosan, and cellulose. Silicic acid polycondensates contain Si-O-Si bonds. Inorganic compounds include silicon cations, optionally in combination with other cations such as aluminum, titanium, boron, or zirconium.

[0250] Examples of seals produced include:

[0251] - a seal consisting of:

[0252] i) Membranes containing greaseproof paper or filter paper

[0253] ii) adhesive layer and / or barrier layer,

[0254] (iii) a nonwoven fabric layer,

[0255] Once implemented in a capsule, layer i) is the outer layer and layer iii) is the inner layer of the capsule;

[0256] - a seal consisting of:

[0257] i) Filter paper membrane,

[0258] ii) barrier layer,

[0259] iii) barrier films, such as cellulose films or PLA films or PHA films,

[0260] iv) a nonwoven fabric layer,

[0261] Once implemented in a capsule, layer i) is the outer layer and layer iv) is the layer inside the capsule;

[0262] - a seal consisting of:

[0263] i) cellulose films or cellulose membranes, e.g.

[0264] ii) a nonwoven fabric layer,

[0265] Once implemented in a capsule, layer i) is the outer layer and layer ii) is the layer inside the capsule;

[0266] - a seal consisting of:

[0267] i) paper membrane or filter paper membrane,

[0268] ii) hybrid barrier layers of organic polymers and inorganic compounds,

[0269] iii) SiOx or Al2O3 barrier layer,

[0270] iv) cellulose barrier films,

[0271] v) a nonwoven fabric layer,

[0272] Once implemented in a capsule, layer i) is the outer layer and layer iv) is the layer inside the capsule;

[0273] - a seal consisting of:

[0274] (i) biopolymer-based membranes such as PHA or PBAT or PBS or poly-aliphatic diacid-co-terephthalate-co-butylene glycol ester (PBAlT), wherein the aliphatic diacid may be, for example, sebacic acid, or PLA,

[0275] ii) barrier layer,

[0276] iii) a biopolymer membrane, such as PHA or PBAT or PBS or PBA1T or PLA,

[0277] Once implemented in a capsule, layer i) is the outer layer and layer iii) is the inner layer of the capsule;

[0278] - a seal consisting of:

[0279] i) barrier layer,

[0280] () biopolymer membranes, such as PHA or PBAT or PBS or poly-aliphatic diacid-co-terephthalate-co-butylene glycol ester (PBAlT), wherein the aliphatic diacid may be, for example, sebacic acid, or PLA,

[0281] Once implemented in a capsule, layer i) is the outer layer and layer ii) is the layer inside the capsule.

[0282] refer to Figure 1 , the container 2 according to the invention consists of a bottom 3 having a substantially circular shape and a side wall 4 provided with a circular edge 5 .

[0283] See also Figure 2 , the capsule 1 according to the invention comprises a container and a seal 6. The container consists of a bottom 3 having a substantially circular shape and a side wall 4 provided with a rounded edge 5. The capsule according to the invention further comprises a substance in powder or liquid form for preparing a beverage (introduced before closing the capsule with the seal), which Figure 2 Not shown in FIG.

[0284] The invention further relates to a method for producing a capsule according to the invention.

[0285] According to a first embodiment, the method according to the invention comprises the following steps:

[0286] a) preparing a formulation by mixing the ingredients, wherein, optionally, the ingredients may be extruded,

[0287] b) injection molding the formulation in a mold so as to form at least the layer of the side wall and the rounded edge of the container, optionally making one or more other layers of at least the side wall and the rounded edge of the container by extrusion using at least one formulation different from the formulation used in step a), for example using a PVOH or EVOH formulation,

[0288] c) optionally, filling a chamber with a substance in powder form,

[0289] d) Optionally, closing the container with a seal to form a capsule.

[0290] When the bottom is not a monolayer or multilayer film, step b) of the manufacturing method preferably comprises the step of injection molding the formulation in a mold so as to form a layer of the container comprising the bottom, side walls and rounded edges.

[0291] When the base is not a monolayer or multilayer film, step b) of the manufacturing method preferably comprises the step of injection molding the formulation in a mold so as to form a layer of a container comprising supports (eg a cross-shaped structure), side walls and rounded edges.

[0292] Alternatively, the method according to the invention comprises the following steps:

[0293] a) preparing a formulation by mixing the ingredients, wherein, optionally, the ingredients may be extruded,

[0294] b) manufacturing a sheet or film by extrusion of the formulation before calendering or blow molding, optionally using at least one formulation different from the formulation in step a) to manufacture one or more other layers of the container by extrusion, for example using a formulation of PVOH or EVOH,

[0295] c) shaping the container by thermoforming the sheet into or into a suitable shape,

[0296] d) optionally, filling the container with a substance in powder or liquid form,

[0297] e) Optionally, closing the container with a seal to form a capsule.

[0298] Preferably, the production process comprises only one step of injection molding or thermoforming using the formulation defined in the present invention. According to said embodiment, the container according to the invention will then consist of only one layer having the formulation defined in the present invention.

[0299] Finally, the invention relates to the use of the formulation defined in the invention for the preparation of capsules having low permeability to gases and moisture.

[0300] Typically, the container of the present invention has a relative humidity of less than 3.5×10 -3 cm 3 / capsule / 24 hours, preferably at 23 ° C and 50% RH (relative humidity) at 0.21 atm is equal to or less than 3.0 × 10 -3 cm 3 / capsule / 24 hours, further preferably at 23 ° C and 50% RH (relative humidity) at 0.21 atm is equal to or less than 2.90 × 10 -3 cm 3 / capsule / 24 hours permeability to oxygen, measured according to the ASTM F1307 standard or the ISO 15105-2 standard. During the permeability measurement test, the container is fastened to the board so that the board "closes" the container.

[0301] Advantageously, the capsule according to the invention has one or more of the following features:

[0302] - a maximum stress of at least 35 MPa, preferably in the range of 35 to 65 MPa, more preferably 39 to 60 MPa; and / or

[0303] - a Young's modulus of at least 900 MPa, preferably in the range of 1000 to 2400 MPa, more preferably 1050 to 2100 MPa; and / or

[0304] - an elongation at maximum stress less than or equal to 8%, preferably ranging from 2% to 8%, more preferably from 2.5 to 7%; and / or

[0305] - a tensile stress of 25 to 80 MPa, preferably 35 to 70 MPa, more preferably 40 to 65 MPa; and / or

[0306] - elongation at break of 1% to 15%, preferably 2 to 10%, more preferably 2.5% to 8%; and / or

[0307] -Charpy Impact Strength ranges from 2 to 20 kJ / m 2, preferably 3 to 15 kJ / m 2 , more preferably 4 to 10 kJ / m 2 .

[0308] Such properties can be measured as described in the experimental section.

[0309] For example, the maximum stress, Young's modulus, the elongation at maximum stress, the breaking stress and the elongation at break are measured in bending according to NF EN ISO 178 standard at a speed of 10 mm / min and advantageously at a temperature between 20 and 23° C. and at a relative humidity between 45 and 55%.

[0310] Advantageously, the Charpy impact strength may be measured according to standard NF ISO 179 at a temperature between 20 and 23° C. and at a relative humidity between 45 and 55%.

[0311] Example

[0312] The following examples illustrate in a non-exhaustive manner the work performed by applicants.

[0313] Example 1: Determination of the crystallinity of polymers P1 and P2

[0314] The different polymers of the PHA series come from various manufacturers.DSC analyses were performed on a TA Instruments DSC 2920 equipment (heating rate: + / -10°C / min; sample weight approximately 20 mg).

[0315] Table 1 below shows the results of thermal analysis, including the polymer melting temperature (Tm), crystallization temperature (Tc_n), cold crystallization temperature (Tcc), melting enthalpy (ΔHM1) and crystallinity (Kc) (wherein the melting enthalpy ΔHM1 of the fully crystalline PHA from the literature is °100% m, PHA = 146.6 J / g).

[0316] [Table 1]

[0317] Tc_n(℃) Tm(℃) ΔHm1(J / g) Tcc(℃) Kc(%) PHBV 10 123 174 83.0 - 57% PHBH 12 62.1 160 23.5 - 16% PHBH 13 65 144 36.8 - 25% PHBH 15 44 107;125;163 14.3 57 10% P3HB4HB 00 49 85 0.29 / 0.2%

[0318] The characterizations make it possible to classify the polymers according to their degree of crystallinity, so they make it possible to classify the polymers according to the designations P1 (rather crystalline) or P2 (weakly crystalline or amorphous).

[0319] Example 2 Formulations based on polymers P1, P2 and other additives - Effect on mechanical properties The applicant produced a number of formulations by extrusion, listed in Table 2 below, where % are % by weight:

[0320] [Table 2]

[0321] Preparation composition F89 80%PHBV 10+20%Kaolinite F90 72%PHBV 10+25%kaolinite+3%triethyl citrate F91 90%PHBV 10+5%P3HB4HB 00+5%Kaolinite F92 85%PHBV10+5%P3HB4HB00+10%Kaolinite F93 80% PHBV 10 + 20% F89 F94 90% (80%PHBV 10 + 20%F89) + 10%P3HB4HB 00

[0322] Formulations F89, F90 and F93 are comparative formulations, whereas formulations F91, F92 and F94 are formulations according to the invention.

[0323] Impact and flexure test pieces (dimensions: L=78 mm; L=10 mm, and EP=4 mm) were produced from the above formulation on a DK 25T press. Furthermore, certain polymers P1 and P2 were injected.

[0324] Table 3 below shows the mechanical properties in bending according to standard NF EN ISO 178, measured on an Adamel Lhomargy dynamometer with a 500 N force sensor at a deformation rate of 10 mm / min.

[0325] The measurements are carried out at temperatures between 20 and 23° C. and at relative humidity between 45 and 55%.

[0326] “Max stress (MPa)” refers to maximum stress.

[0327] "Elongation at maximum stress" means the elongation at maximum stress.

[0328] "Breaking stress" refers to the ultimate stress.

[0329] The samples tested were the polymers in Table 1 and the formulations in Table 2.

[0330] [Table 3]

[0331]

[0332] The formulations according to the invention have a Young's modulus of about 1000 to 1410 MPa. The above shows that the formulations according to the invention are not very rigid compared to control formulations or even polymers, which gives them the flexibility that is sought in the art.

[0333] As for the elongation at break, which defines the ability of a material to elongate before breaking when stressed in tension or bending, the results obtained for the formulation according to the invention were about 5% to 7%, indicating a better ability of the mixture to deform before breaking.

[0334] Table 4 below gives the charpy impact strength (A) measured according to standard NF ISO 179. cu The measurements were carried out at a temperature between 20 and 23° C. and at a relative humidity between 45 and 55%.

[0335] [Table 4]

[0336] <![CDATA[A cu Impact strength [kJ / m 2 ]]]> PHBH 12 27.4+ / -2.7 PHBH 13 35.5+ / -2.8 PHBH 15 46.7+ / -1.7 PHBV 10 4.2+ / -1.1 F89 3.4+ / -0.6 F90 5.8+ / -2.1 F91 7.8+ / -0.9 F92 7.6+ / -1.0 F93 4.4+ / -1.3 F94 8.7+ / -0.7

[0337] For the polymers, PHBH 12 and PHBV 15 showed no impact breakage, while PHBH 13 and PHBV 10 experienced complete breakage.

[0338] Furthermore, the formulations according to the invention show a certain flexibility compared to formulations not comprising a P2 polymer. In fact, the examples in Table 4 illustrate the interest of the invention: the results obtained for the comparative formulations F89, F90 and F93, which do not contain a P2 polymer (less crystalline or more amorphous), show that the formulations are too brittle, whereas the formulations F91, F92 and F94 according to the invention allow better properties to be obtained. In fact, the incorporation of a P2 polymer serves to bring flexibility and impact strength to the final composition, resulting in a good functionality of use of the capsule.

[0339] Tables 3 and 4 show that the capsules according to the invention have better impact strength and better elongation at break than formulations not according to the invention, which are important factors affecting the fragility of the capsules during the production line or during use.

[0340] The Applicant also measured the thermal properties of the formulations. Table 5 below shows the crystallinity of formulations F90 to F94, following the same procedure as for polymers P1 and P2 (Example 1).

[0341] [Table 5]

[0342] Tc_n(℃) Tm(℃) ΔHm1(J / g) Kc1(%) F90 120 171 83.3 79% F91 124 174 87.7 67% F92 125 174 85.3 69% F93 127 174 107.5 77% F94 124 174 79.5 63%

[0343] The results obtained according to Table 5 show that the addition of P2 polymer serves to improve the mechanical properties, especially the impact resistance.

[0344] Example 3: Rheological properties and thermal stability stability

[0345] Plastics processing processes for polymer application and shaping generate significant shear rates, about 10 for extrusion and injection. 4 sec -1 , which induces a decrease in molecular weight and thus a loss of properties due to chain breaking. The same applies to thermal stress, which causes chain scission due to thermo-oxidation.

[0346] Applicants conducted thermal stability studies on certain polymers and certain formulations to measure the effect of adding a P2 polymer to a P1 type polymer.

[0347] Characterization using a plastometer: temperature 183°C; load 2.16 kg; all materials baked at 80°C for 2 hours.

[0348] Figure 3 The formulation flow (MFR) as a function of time in the plastometer is shown.

[0349] like Figure 3 As shown, surprisingly and unexpectedly, polymer P2 thermally stabilizes polymer P1 and formulations based thereon.

[0350] The realization of the formulation according to the invention is therefore greatly facilitated.

[0351] Example 4: Study on the Effect on Oxygen Permeability

[0352] The oxygen permeability of the capsules obtained from different polymers and different formulations was measured according to standards ASTM F1307 or ISO 15105-2.

[0353] Table 6 shows the results obtained for oxygen permeability.

[0354] [Table 6]

[0355] <![CDATA[[cm 3 / capsule / 24 hours at 0.21 atm] at 23°C and 50% RH]]> PHBH 13 <![CDATA[6.6x10 -3 ]]> PHBV 10 <![CDATA[2.4x10 -3 ]]> F89 <![CDATA[1.3x10 -3 ]]> F90 <![CDATA[3.1x10 -3 ]]> F91 <![CDATA[2.35x10 -3 ]]> F92 <![CDATA[2.25x10 -3 ]]> F93 <![CDATA[1.9x10 -3 ]]> F94 <![CDATA[2.85x10 -3 ]]>

[0356] As mentioned before, the addition of P2 polymer did not significantly reduce the material’s permeability to oxygen, while greatly improving the mechanical and thermal properties of the capsules.

[0357] The best oxygen permeability was obtained with the comparative formulations F93 and F89, but the impact strength and elongation at break values ​​were low, with a high degree of crystallinity, which had the effect of weakening the capsules, making them brittle during transport, when passing through a filling line, or when used in a machine for extracting the beverage.

[0358] Compared to the comparative formulations, formulations F91, F92 and F94 according to the invention have a plasticizing effect, wherein the inorganic filler is added to increase the permeability to oxygen without being significantly detrimental to the oxygen permeability of the final formulation.

[0359] In summary, the subject of the invention is of a fourfold significance: the controlled combination according to the invention of a polymer P1 having a crystallinity greater than or equal to 50% and the addition of a polymer P2 having a crystallinity less than or equal to 30% and more particularly less than or equal to 5%, with or without additions (inorganic fillers, plasticizers, etc.), contributes to:

[0360] -Meeting the mechanical performance requirements of the capsule for use in a machine for extracting beverages, the P2 polymer provides impact strength and flexibility;

[0361] -Meet the mechanical property requirements of the capsule during transportation and during transfer on the filling line, the P2 polymer provides impact strength and flexibility;

[0362] - provide a very good level of permeability to gases, in particular to oxygen: even at low concentrations, the P2 polymers make it possible to obtain a high degree of crystallinity, with or without nucleating agents, the P2 polymers being weakly crystalline or even amorphous in nature,

[0363] - Improves thermal stability of formulations when used in plastics processing, at high shear rates and at elevated temperature levels.

[0364] Thus, the presence of at least one amorphous polymer having a degree of crystallinity less than or equal to 5% in the capsule formulation makes it possible to obtain capsules that meet the oxygen permeability requirements and do not rupture, even if the container consists of a monolayer formulation, while remaining biodegradable, in particular under industrial composting and domestic composting conditions (aerobic bioprocesses) or by anaerobic digestion (anaerobic bioprocesses).

[0365] In conclusion, the capsules obtained according to the invention, i.e. the capsules obtained from the formulation comprising a weakly crystalline or relatively amorphous polymer and a relatively crystalline polymer, are not brittle and have consistently good rigidity as well as impact resistance and elongation at break, sufficient to be comparable to Such good mechanical strength and oxygen barrier properties cannot be achieved with the addition of plasticizers such as Citrofol.

[0366] Thus, the presence of at least one weakly crystalline or relatively amorphous copolymer of the PHA series in the capsule formulation makes it possible to obtain capsules that meet the oxygen permeability requirements and do not rupture, even if the container consists of a monolayer formulation, while remaining biodegradable, in particular under industrial and domestic composting conditions.

Claims

1. Capsule (1) for preparing a beverage, comprising a container (2), the container (2) comprising at least one side wall (4) having a rounded edge (5), characterized in that The sidewall and the rounded edge are formed by injection molding or thermoforming of a formulation comprising at least one of: (i) at least one polymer P1 selected from polyhydroxyalkanoates (PHA); and (ii) at least one polymer P2 selected from polyhydroxyalkanoates (PHA), The crystallinity (KC1) of the polymer P1 is greater than or equal to 50%, And the crystallinity (KC2) of the polymer P2 is less than or equal to 30%, preferably less than or equal to 5%.

2. The capsule according to claim 1, characterized in that The polyhydroxyalkanoate is selected from: polyhydroxybutyrate (PHB) polymers, preferably the polymer P1 and / or the polymer P2 is a PHB copolymer.

3. The capsule according to claim 1, characterized in that The polymer P1 contains a monomer unit M1a of hydroxybutyrate 3HB and a monomer unit M1b selected from hydroxyvalerate HV, 3-hydroxyhexanoate HH, or 4-hydroxybutyrate 4HB, M1a is different from M1b, and / or the polymer P2 contains a monomer unit M2a of hydroxybutyrate 3HB and a monomer unit M2b selected from hydroxyvalerate HV, 3-hydroxyhexanoate HH, or 4-hydroxybutyrate 4HB, M2a is different from M2b, preferably the weight ratio M1b / M1a is less than or equal to 0.7, preferably less than or equal to 0.6, and / or the weight ratio M2b / M2a is greater than or equal to 0.05, preferably in the range of 0.1-1, or preferably 0.2-0.

9.

4. The capsule according to claim 1, characterized in that The polymer P1 and / or the polymer P2 are obtained in a bio-based manner by aerobic and / or anaerobic fermentation processes.

5. The capsule according to any one of claims 1 to 4, characterized in that The polymer P1 represents 70 to 99 wt %, preferably 80 to 98 wt %, of the total weight of polymers P1 and P2, and / or the polymer P2 represents 1 to 30 wt %, preferably 2 to 20 wt %, or preferably 3 to 10 wt %, of the total weight of polymers P1 and P2.

6. The capsule according to any one of claims 1 to 5, characterized in that The formulation comprises from 50 to 99.9% by weight, preferably from 75 to 99.5% by weight, advantageously from 90 to 99% by weight, of polymers P1 and P2, relative to the total weight of the formulation.

7. The capsule according to any one of claims 1 to 6, characterized in that The formulation further comprises at least one inorganic or organic filler, preferably in a proportion ranging from 0.1 to 50% by weight, preferably from 0.5 to 25% by weight, advantageously from 1 to 15% by weight, relative to the total weight of the formulation, preferably the filler is chosen from: silicon dioxide, silicates, double hydroxides (HDL), titanium oxide, vitamin E, plasticized animal or plant proteins, or mixtures thereof.

8. The capsule according to claim 7, characterized in that The BET specific surface area of ​​the silicate is 1 to 250 m 2 / g, and / or the median diameter of the silicate is between 0.5 and 20 μm, and / or the size shape factor of the silicate is greater than or equal to 1:

2.

9. The capsule according to any one of claims 1 to 8, wherein The formulation further comprises at least one polyvinyl alcohol or ethylene vinyl alcohol, preferably in an amount ranging from 1 to 30% by weight, preferably from 2 to 20% by weight, advantageously from 5 to 10% by weight relative to the total weight of the formulation.

10. The capsule according to any one of claims 1 to 9, wherein the capsule: - is biodegradable and / or compostable under industrial or domestic conditions or by anaerobic digestion, and / or - contains at least 80% by weight of bio-based carbon, relative to the total weight of carbon atoms of the capsule.

11. Capsule according to any one of claims 1 to 10, wherein the container comprises a bottom, and wherein the bottom, side walls and rounded edges are formed by injection moulding or thermoforming, preferably with only one layer of the formulation in a mould.

12. Capsule according to any one of claims 1 to 11, containing a substance in powder or liquid form, the capsule comprising a seal (6) welded around the edge of the container, preferably the seal comprising a single or multilayer film, the film comprising one or more of the following materials, the materials are selected from materials that are biodegradable and compostable according to an aerobic biological process, and / or materials that can be decomposed by anaerobic digestion according to an anaerobic process, preferably the materials are selected from paper, non-woven fabrics, cellulose, SiOx layers, polylactic acid polymers, polyhydroxyalkanoates, hybrid layers of organic polymers and inorganic fibers, layers coated with polyvinyl alcohol or ethylene-vinyl alcohol copolymers, preferably layers metallized with aluminum, the material layers optionally being separated by adhesive layers.

13. The capsule of claim 12, wherein the seal is composed of a multilayer film comprising: 1) a membrane of paper or filter paper, ii) a barrier layer, preferably the barrier layer comprises one or more layers selected from the following: - a hybrid barrier layer comprising an organic polymer and an inorganic compound, and / or -SiOx barrier, and / or - Cellulose barrier layer, iii) a nonwoven fabric layer, said nonwoven fabric layer being within the capsule.

14. The capsule of claim 12, wherein the seal consists of: Multilayer films comprising: i) barrier layer, ii) a membrane containing a biopolymer, such as polyhydroxyalkanoate PHA, or polybutylene adipate terephthalate PBAT, or polybutylene succinate PBS, or polyaliphatic diacid-co-terephthalate-co-butylene ester PBAlT, or polylactic acid PLA, or a multilayer film comprising: i) a membrane containing a biopolymer, such as polyhydroxyalkanoate PHA, or polybutylene adipate terephthalate PBAT, or polybutylene succinate PBS, or polyaliphatic diacid-co-terephthalate-co-butylene ester PBAlT, or polylactic acid PLA, ii) barrier layer, iii) Membranes containing biopolymers such as polyhydroxyalkanoate PHA, or polyadipate-co-terephthalate-co-butylene glycol PBAT, or polybutylene succinate PBS, or polyaliphatic diacid-co-terephthalate-co-butylene glycol PBAlT, or polylactic acid PLA.

15. The method for manufacturing a capsule according to any one of claims 1 to 14, comprising the following steps: a) preparing a formulation by mixing the ingredients, wherein the ingredients may optionally be extruded, b) injection molding the formulation obtained in step a) in a mold so as to form at least the side wall (4) and the rounded edge (5) layers of the container (2), optionally one or more layers of the container (2) may be injection molded using a formulation different from the formulation in step a), c) filling the container (2) with the substance in powder or liquid form, if the bottom is not molded by injection molding the formulation, the filling step is preceded by the steps of placing a single or multiple layer bottom to form the container, d) optionally, closing the container (2) with a seal so as to form a capsule, Or the manufacturing method comprises the following steps: a) preparing a formulation by mixing the ingredients, wherein the ingredients may optionally be extruded, b) producing a sheet or film by extrusion of said formulation before calendering or blow molding, optionally producing one or more other layers of the side wall (4) and the rounded edge (5) of the container by extrusion using at least one formulation different from the formulation of step a), for example using a formulation of PVOH or EVOH, c) shaping by thermoforming the sheet or film into a suitable shape, d) filling the container (2) with the substance in powder or liquid form, if the bottom is not shaped by thermoforming during step c), the filling step is preceded by the steps of placing a single or multiple layer bottom to form the container, e) Optionally, closing the container (2) using a seal to form a capsule.